Location History:
- Daly City, CA (US) (1999 - 2005)
- Belmont, CA (US) (2010 - 2016)
- South San Francisco, CA (US) (2011 - 2018)
Company Filing History:
17 out of 3,221 
9 out of 168 
2 out of 4 
Years Active: 1999-2018
Title: Richard A. Goldsmith: Innovator in Pharmaceutical Compounds
Introduction
Richard A. Goldsmith, based in Daly City, CA, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 21 patents. His innovative work mainly revolves around the development of pharmaceutical compounds that target lipid kinases, showcasing his commitment to enhancing medical treatments for disorders such as cancer.
Latest Patents
Goldsmith's recent patents include groundbreaking pharmaceutical compounds formulated to inhibit lipid kinases, particularly PI3K. One notable patent describes compounds of Formulae Ia, along with their stereoisomers, geometric isomers, tautomers, solvates, metabolites, and pharmaceutically acceptable salts. These compounds are instrumental in diagnosing, preventing, and treating disorders mediated by lipid kinases in mammalian cells.
Another significant patent emphasizes phosphoinositide 3-kinase inhibitor compounds with specific structures, including Formulas Ia-d, where X is S or O, mor is a morpholine group, and R is a monocyclic heteroaryl group. This innovation serves to modulate the activity of lipid kinases and further advances treatment options for cancers related to these enzymes.
Career Highlights
Goldsmith has contributed his expertise to renowned companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His tenure at these establishments allowed him to collaborate on cutting-edge research and development in the pharmaceutical sector, ultimately leading to his vast collection of patents.
Collaborations
Throughout his career, Richard A. Goldsmith has worked alongside talented individuals such as Alan G. Olivero and Adrian Folkes. These collaborations have enriched his research and helped propel innovative ideas into practical applications within the pharmaceutical industry.
Conclusion
In summary, Richard A. Goldsmith stands out as an influential inventor in the pharmaceutical realm, particularly noted for his work on inhibitors of lipid kinases. His 21 patents reflect a dedication to advancing medical science and improving treatment options for serious conditions like cancer. As he continues to innovate, the impact of his work will likely resonate across the medical community for years to come.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.